The Centers for Disease Control and Prevention (CDC) is offering this grant to fund research into effective public health interventions for glaucoma detection and management. This grant is for investigating the feasibility, effectiveness, and cost-effectiveness of high-quality, innovative strategies among high-risk populations within community-based healthcare settings. Glaucoma is a major cause of irreversible blindness, particularly affecting African Americans, with many unaware of their condition. Projects funded will focus on comparative effectiveness trials (Component A) or serve as a coordinating center (Component B). The CDC seeks proposals for cost-effective, comprehensive strategies utilizing allied health professionals and advanced technologies, demonstrating potential for real-world adoption and significant impact on population health.
Opportunity ID: 348858
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 7 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Feb 21, 2024 |
Original Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 21, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | City or township governments Special district governments County governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public and State controlled institutions of higher education Private institutions of higher education For profit organizations other than small businesses State governments Independent school districts Small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso, Scientific Program Official
uxl8@cdc.gov Email:uxl8@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
See Related Documents, Revised Full Announcement, for latest version. | Feb 21, 2024 | |
Modified to extend deadline of application due date to 3/22/2024, increase eligibility for Component B applicants, reduce description of research plan for Component B. | Nov 28, 2023 | |
Modified to extend deadline for application due date to 3/22/2024, increase eligibility for Component B applicants, reduce description of research plan for Component B, | Nov 28, 2023 | |
Please see NOFO for update to definitions. | Nov 28, 2023 | |
Updating the date of the Pre-Application call. All other information and application package to remain the same. | Nov 28, 2023 | |
CFDA change | Nov 28, 2023 | |
Nov 28, 2023 | ||
Jun 21, 2023 |
DISPLAYING: Synopsis 7
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 7 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Feb 21, 2024 |
Original Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 21, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | City or township governments Special district governments County governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public and State controlled institutions of higher education Private institutions of higher education For profit organizations other than small businesses State governments Independent school districts Small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso, Scientific Program Official
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Synopsis 6
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 6 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Feb 20, 2024 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 21, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso, Scientific Program Official
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Synopsis 5
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 5 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Feb 20, 2024 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Mar 22, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 21, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | Amendment III February 16, 2024Extended deadline, increased eligibility for Component B applicants, reduced description of research plan for Component B, per below. PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso, Scientific Program Official
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Synopsis 4
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Jan 23, 2024 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 22, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso, Scientific Program Official
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Dec 12, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Mar 06, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | PRE-APPLICATION WEBINAR UPDATE The pre-application informational webinar will be held January 9, 2024 at 1:00 – 2:00 PM. Pre-registration is not required. Meeting URL: https://cdc.zoomgov.com/j/1618519033?pwd=UEN5WDFncGEvbHBNcXU4QmZFZHQrUT09&from=addon. Meeting ID: 161 851 9033. Passcode: 161 851 9033DESCRIPTION – The purpose of this notice of funding opportunity is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components. Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Component B: A coordinating center to harmonize data collection and analysis, and logistic and communication support to enhance the efficiency and productivity for component A. Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. This NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs. CDC intends to further research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso, Scientific Program Official
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Nov 28, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Mar 06, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B: A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Nov 28, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Mar 06, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $950,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B: A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Alison Amoroso
uxl8@cdc.gov Email:uxl8@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DP-24-081 |
Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Jun 21, 2023 |
Last Updated Date: | Jun 21, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Feb 26, 2024 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | $750,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B: A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
Link to Additional Information: | https://sightstudies.org |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:uxl8@cdc.gov |
Related Documents
Folder 348858 Full Announcement-Full Announcement -> Foa_Content_of_RFA-DP-24-081 Final.pdf
Folder 348858 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_RFA-DP-24-081 Modification.pdf
Folder 348858 Other Supporting Documents-Additional Information -> Additional Information – RFA-DP-24-081.pdf
Folder 348858 Other Supporting Documents-Additional Information -> Q and A for RFA-DP24-081.pdf
Folder 348858 Other Supporting Documents-Additional Information -> RFA-DP-24-081, Final Q and A for publishing – Final.pdf
Folder 348858 Other Supporting Documents-Additional Information -> UPDATE to PRE-APPLICATION WEBINAR LINK RFA-DP-24-081.pdf
Packages
Agency Contact Information: | Alison Amoroso, Scientific Program Official uxl8@cdc.gov Email: uxl8@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.068 | RFA-DP-24-081 | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings | PKG00283931 | Feb 21, 2024 | Mar 22, 2024 | View |
Package 1
Mandatory forms
348858 RR_SF424_5_0-5.0.pdf
348858 RR_Budget_3_0-3.0.pdf
348858 PHS398_ResearchPlan_5_0-5.0.pdf
348858 PHS398_CoverPageSupplement_5_0-5.0.pdf
348858 RR_OtherProjectInfo_1_4-1.4.pdf
348858 PerformanceSite_4_0-4.0.pdf
348858 RR_KeyPersonExpanded_4_0-4.0.pdf
348858 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
348858 RR_SubawardBudget30_3_0-3.0.pdf